MEETINGS - Meeting on Corporate Compliance Audits (US) July 1995:
This article was originally published in Clinica
A meeting on Corporate Compliance Audits: what you can do to protect your company's consumers, officers and shareholders will be held on July 11th, 1995, in Washington, DC, US. For further details, contact: FDLI, Conference Registration Dept, 79304 Baltimore, MD 21279-0304, US. Tel: +1 (202) 371 1420. Fax: +1 (202) 371 1420.
You may also be interested in...
Moderate growth at Bristol-Myers Squibb and Amgen moved the two companies into the top 10 pharma ranks, based on the most recent Scrip 100 rankings, while declining growth at Gilead and Teva moved those drug makers out.
Momenta Pharmaceuticals has agreed to pay $35.0m to settle claims that it manipulated generic approval processes in the US to shut competitor Amphastar out of the US enoxaparin market.